Abstract
Healthcare-associated infections (HAIs) are an important cause of morbidity and mortality in the USA. They are associated with a substantial increase in health care costs each year. Fortunately, many HAIs are preventable, and their eradication is a national priority. Chlorhexidine (CHG) bathing has been used as an infection prevention measure, either alone or bundled with other interventions, with mostly beneficial results. The recent surge in its use as an agent of choice for skin antisepsis has lead to concerns over emerging resistance among microorganisms. Moreover, compliance with CHG-bathing protocols is not routinely monitored. Policies developed to determine the best infection prevention practice must consider that a “one-size-fits-all” strategy may lead to the selection of CHG-tolerant microorganisms, thereby emphasizing the need for more robust guidelines and additional studies on the role of chlorhexidine bathing for the prevention of HAIs.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Scott DR. Center for Disease Control and Prevention. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention. 2009; Available at: http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf.
Zimlichman E, Henderson D, Tamir O. Health care-associated infections: a meta-analysis of costs and financial impact on the us health care system. Jama Intern Med. 2013;173(22):2039–46.
Centers for Disease Control and Prevention. 2013 National and State Healthcare-Associated Infections Progress Report. Published January 14, 2015. Available at www.cdc.gov/hai/progress-report/index.html.
Magill SS, Jonathan RE. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198–208.
Climo MW, Yokoe DS, Warren DK. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368(6):533–42. Multicenter, cluster-randomized, nonblinded crossover trial to evaluate daily bathing with chlorhexidine-impregnated washcloths and its effect on infection.
Harris AD, Pineles L, Belton B. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA. 2013;310(15):1571–80.
Huang SS, Septimus E, Kleinman K, for the CDC Prevention Epicenters Program and the AHRQ DECIDE Network and Healthcare-Associated Infections Program, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368:2255–65. Discusses the trial of a pragmatic, cluster-randomized trial with random hospitals using multiple strategies to fight MRSA.
O’Grady NP, Alexander M. Center for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections 2011. Can be accessed at: http://www.cdc.gov/hicpac/BSI/01-BSI-guidelines-2011.html.
Abdallah C. Perioperative chlorhexidine allergy: is it serious? J Anaesthesiol Clin Pharmacol. 2015;31(2):152–4.
Siebert J, Harke H. Disinfectatnts. Ullmann’s Encyclopedia of Industrial Chemistry. Wiley Online Library. 2009.
Davies GE, Francis J, Martin AR, Rose FL, Swain G. 1:6-di-4′-chlorophenyldiguanidohexane (“hibitane”). Laboratory Investigation of a new antibacterial agent of high potency. Br J Pharmacol Chemother. 1954;9(2):192–6.
Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;30(8):815.
Dicks KV, Lofgren E, Lewis SS, Moehring RW, Sexton DJ, Anderson DJ. A multicenter pragmatic interrupted time series analysis of chlorhexidine gluconate bathing in community hospital intensive care units. Infect Control Hosp Epidemiol. 2016;10:1–7. Discusses using 33 community hospitals in the DUKE INFECTION CONROL OUTREACH NETWORK FROM 2008-2013 and the usage of CHG bathing.
Chung YK, Kim JS, Soon S, et al. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity. Am J Infect Control. 2015;43(11):1171–7.
Cassir N, Papazian L, Fournier P-E, Roult D. Insights into bacterial colonization of intensive care patients’ skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis. 2015;34:999–1004.
Kim HY, Lee WK, Na S, Roh YH. The effects of chlorhexidine gluconate bathing on health care-associated infection in intensive care units: a meta-analysis. J Crit Care. 2015 in press.
Gidengil CA, Gay C, Huang SS, Platt R, Yokoe D, Lee GM. Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit. Infect Control Hosp Epidemiol. 2015;36(1):17–27.
Hayden MK, Lin MY, Weiner S, Blom D, et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis. 2015;60(8):1153–61.
Haverkate MR, Bootsma MC, Weiner S, Blom D. Modeling spread of KPC-producing bacteria in long-term acute care hospitals in the Chicago region. USA Infect Control Hosp Epidemiol. 2015;36(10):1148–54.
Cassir N, Thomas G, Hraiech S, et al. Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control. 2015;43(6):640–3.
Shah HN, Schwartz JL, Luna G, Cullen DL. Bathing with 2% chlorhexidine gluconate: evidence and costs associated with central line-associated bloodstream infections. Crit Care Nurs Q. 2016;39(1):42–50.
Choi EY, Park D-A, Kim HJ, Park J. Efficacy of chlorhexidine bathing for reducing healthcare associated bloodstream infections: a meta-analysis. Ann Intensive Care. 2015;5:31.
Noto MJ, Domenico HJ, Byrne DW, et al. Chlorhexidine bathing and healthcare-associated infections: a randomized clinical trial. JAMA. 2015;313(4):369–78. Discusses if CHG bathing helps critically ill patients with health care-associated infections.
Rauji CM, Clay K, Velasco C, Yu LC. Daily bathing with chlorhexidine and its effects on nosocomial infection rates in pediatric oncology patients. Pediatr Hematol Oncol. 2015;32(5):315–21.
Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteremia in critically ill children: a multicenter, cluster-randomized, two-period crossover trial. Lancet. 2013;381(9872):1099–106.
Chen W, Cao Q, Li S, Li H, Zhang W. Impact of daily bathing with chlorhexidine gluconate on ventilator associated pneumonia in intensive care units: a meta-analysis. J Thorac Dis. 2015;7(4):746–53.
Edminston Jr CE, Assadian O, Spencer M, et al. To bathe or not to bathe with chlorhexidine gluconate: is it time to take a stand for preadmission bathing and cleansing? AORN J. 2015;101(5):529–38.
Leaper D, Ousey K. Evidence update on prevention of surgical site infection. Curr Opin Infect Dis. 2015;28(2):158–63.
Sasi SP, Sistla SC, Sistla S, Karthikeyan VS, Mahalakshmy T, Ali SM, et al. Decolonisation of MRSA and its effect on surgical site infections—a study in a tertiary care institute. Int J Clin Pract. 2015;69(3):366–74.
Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev. 2015;20(2):CD004985.
Centers for Disease Control and Prevention. Draft guideline for the prevention of surgical site infections. Fed Regist. 2014;79(67):19339.
Mangram AJ et al. Guideline for prevention of surgical site infection 1999. Hospital Infection Control Practices Advisory Committee. 1999.
Huang SS et al. Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial. Lancet Infect Dis. 2015;16(1):70–9.
Hines AG, Nuss S, Rupp ME. Chlorhexidine bathing of hospitalized patients: beliefs and practices of nurses and patient care technicians, and potential barriers to compliance. Infect Control Hosp Epidemiol. 2015;36(8):993–4.
Supple L, Kumaraswami M, Kundrapu S, et al. Chlorhexidine only works if applied correctly: use of a simple colorimetric assay to provide monitoring and feedback on effectiveness of chlorhexidine application. Infect Control Hosp Epidemiol. 2015;36(9):1095–7.
Best D, Osterkamp E, Demmel K et al. Increasing activities of daily living is as easy as 1-2-3. J Pediatr Oncol Nurs. 2015.
Warren DK, Prager M, Munigala S, Wallace MA, Kennedy CR, Bommarito KM, et al. Prevalence of qacA/B genes and mupirocin resistance among methicillin-resistant staphylococcus aureus (MRSA) isolates in the setting of chlorhexidine bathing without mupirocin. Infect Control Hosp Epidemiol. 2016;2:1–8.
Vali L, Dashti AA, El-Shazly S, Jadaon MM. Klebsiella oxytoca with reduced sensitivity to chlorhexidine isolated from a diabetic foot ulcer. Int J Infect Dis. 2015;34:112–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Salma Abbas and Sangeeta Sastry have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the authors.
Additional information
This article is part of the Topical Collection on Healthcare Associated Infections
Rights and permissions
About this article
Cite this article
Abbas, S., Sastry, S. Chlorhexidine: Patient Bathing and Infection Prevention. Curr Infect Dis Rep 18, 25 (2016). https://doi.org/10.1007/s11908-016-0532-y
Published:
DOI: https://doi.org/10.1007/s11908-016-0532-y